EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

Australian researchers have developed a portable point-of-care test that detects four common...

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

The success of a cervical cancer elimination program has led to the signing of a memorandum of...

Content from other channels on our network

How Floor Scrubbers Support Infection Prevention In Healthcare

The AI Revolution in Clinical Trials: New Research Reveals Why Industry Leaders Are Making the Shift Now

Medicine shortages are testing Australia's health system and clinicians need national support

A Day in the Life of a home support clinical care team manager

Mindfulness and endoscopies — a more effective combination?

Managing the hygiene gap between cleans in cold-chain environments

Save Food Initiative strengthens global alliance with UNIDO and WPO

Food metal detector solves dairy product effect

Nutrient content claims on alcohol, Australian research

Fast detection of beverage spoilage using the SureTect Multiplex PCR Assay

How can you reduce lab waste without sacrificing results?

Australia Post sets 2030 emissions targets

UNSW tracks groundwater recharging: study

$320m to power Western Sydney International Airport

Water-repellent membrane advances desalination